$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC.

2025 Q1 Form 10-Q Financial Statement

#000164033425000046 Filed on January 08, 2025

View on sec.gov

Income Statement

Concept 2025 Q1 2024 Q3 2023 Q3
Revenue $23.53K $32.46K
YoY Change -27.49% 27.81%
Cost Of Revenue $12.51K $10.45K
YoY Change 19.7% 7.73%
Gross Profit $11.02K $22.01K
YoY Change -49.9% 40.23%
Gross Profit Margin 46.84% 67.8%
Selling, General & Admin $15.66K $92.23K
YoY Change -83.02% 25.09%
% of Gross Profit 142.09% 419.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $169.1K $92.23K
YoY Change 83.38% 25.09%
Operating Profit -$158.1K -$70.22K
YoY Change 125.15% 20.99%
Interest Expense $109.8K $65.90K
YoY Change 66.64% -13.64%
% of Operating Profit
Other Income/Expense, Net -$612.0K -$555.1K
YoY Change 10.25% -9.48%
Pretax Income -$770.1K -$625.4K
YoY Change 23.15% -6.84%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$770.1K -$625.4K
YoY Change 23.15% -6.84%
Net Earnings / Revenue -3272.61% -1926.82%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 4.505B shares 3.955B shares 3.712B shares
Diluted Shares Outstanding 14.76B shares 10.20B shares

Balance Sheet

Concept 2025 Q1 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.150K
YoY Change -74.98%
Cash & Equivalents $12.84K $3.153K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.84K $3.153K
YoY Change 307.07% -84.3%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$3.00
YoY Change -175.0%
TOTAL ASSETS
Total Short-Term Assets $12.84K $3.153K
Total Long-Term Assets -$3.00
Total Assets $3.150K
YoY Change -84.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $652.7K
YoY Change 1303.05%
Accrued Expenses $608.5K
YoY Change 56.58%
Deferred Revenue
YoY Change
Short-Term Debt $1.021M
YoY Change 13.4%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.687M $5.032M
YoY Change 13.01% -12.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.687M $5.032M
Total Long-Term Liabilities $0.00
Total Liabilities $5.032M
YoY Change -12.43%
SHAREHOLDERS EQUITY
Retained Earnings -$10.91M -$10.07M
YoY Change 8.4% -5.45%
Common Stock $4.505M $3.712M
YoY Change 21.37% 4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.674M -$5.029M
YoY Change
Total Liabilities & Shareholders Equity $12.84K $3.153K
YoY Change 307.07% -84.3%

Cashflow Statement

Concept 2025 Q1 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$770.1K -$625.4K
YoY Change 23.15% -6.84%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$61.70K
YoY Change 371.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 61.44K
YoY Change
NET CHANGE
Cash From Operating Activities -61.70K
Cash From Investing Activities
Cash From Financing Activities 61.44K
Net Change In Cash -260.0
YoY Change -98.01%
FREE CASH FLOW
Cash From Operating Activities -$61.70K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8009362
dei Entity Address Address Line1
EntityAddressAddressLine1
6955 North Durango Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite1115-129
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89149
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
505-0743
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2025Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4504844036 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12835 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
12835 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5295 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1932 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10495 usd
CY2024Q3 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
721128 usd
CY2023Q4 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
642128 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
856135 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
669015 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
340000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
340000 usd
CY2024Q3 boty Convertible Notes In Default
ConvertibleNotesInDefault
705974 usd
CY2023Q4 boty Convertible Notes In Default
ConvertibleNotesInDefault
619530 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
98108 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
64016 usd
CY2024Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
114892 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
84428 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2946476 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1838806 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5686537 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4204402 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4504844036 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3896928536 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
4504846 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3896930 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
734640 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1206572 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10913188 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9302609 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5673702 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4199107 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12835 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5295 usd
CY2024Q3 us-gaap Revenues
Revenues
23533 usd
CY2023Q3 us-gaap Revenues
Revenues
32455 usd
us-gaap Revenues
Revenues
103041 usd
us-gaap Revenues
Revenues
88758 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
12509 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
10449 usd
us-gaap Cost Of Revenue
CostOfRevenue
70052 usd
us-gaap Cost Of Revenue
CostOfRevenue
51252 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
11024 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
22006 usd
us-gaap Gross Profit
GrossProfit
32989 usd
us-gaap Gross Profit
GrossProfit
37506 usd
CY2024Q3 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
us-gaap Salaries And Wages
SalariesAndWages
90000 usd
us-gaap Salaries And Wages
SalariesAndWages
90000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15664 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14549 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40178 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41475 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
103456 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
47676 usd
us-gaap Professional Fees
ProfessionalFees
179708 usd
us-gaap Professional Fees
ProfessionalFees
72822 usd
CY2024Q3 boty Professional Fees Related Party
ProfessionalFeesRelatedParty
20000 usd
CY2023Q3 boty Professional Fees Related Party
ProfessionalFeesRelatedParty
0 usd
boty Professional Fees Related Party
ProfessionalFeesRelatedParty
20000 usd
boty Professional Fees Related Party
ProfessionalFeesRelatedParty
0 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
169120 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
92225 usd
us-gaap Operating Expenses
OperatingExpenses
329886 usd
us-gaap Operating Expenses
OperatingExpenses
204297 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-158096 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-70219 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-296897 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-166791 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
109820 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
65902 usd
us-gaap Interest Expense
InterestExpense
287528 usd
us-gaap Interest Expense
InterestExpense
204141 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-502228 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-423719 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1026154 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
606803 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-612048 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-489621 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1313682 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
402662 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-770144 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-559840 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1610579 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
235871 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-770144 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-559840 usd
us-gaap Net Income Loss
NetIncomeLoss
-1610579 usd
us-gaap Net Income Loss
NetIncomeLoss
235871 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4371604302 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3711714036 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4056308720 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3711714036 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14763349460 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10200924610 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14448053878 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10200924610 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4199107 usd
CY2024Q1 boty Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
19700 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2229800 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6409207 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1389365 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5019842 usd
CY2024Q3 boty Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
26284 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
70000 usd
CY2024Q3 boty Stock Issued During Period Value Share Based Compensation Related Parties
StockIssuedDuringPeriodValueShareBasedCompensationRelatedParties
20000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-770144 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001407704
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-5673702 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
51 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
51 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4504844036 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3896928536 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55498
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4572242 usd
dei Entity Registrant Name
EntityRegistrantName
LINGERIE FIGHTING CHAMPIONSHIPS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-72126 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4644368 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
867837 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3776531 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-559840 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-4336371 usd
us-gaap Profit Loss
ProfitLoss
-1610579 usd
us-gaap Profit Loss
ProfitLoss
235871 usd
us-gaap Share Based Compensation
ShareBasedCompensation
70000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
boty Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
20000 usd
boty Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
0 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-1026154 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
606803 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
100408 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
39112 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8563 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1525 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
79000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
74460 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
187120 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
165585 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-136460 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-93300 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
144000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
86444 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
144000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86444 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7540 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6856 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10009 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12835 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3153 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
boty Debt Discount Recognized From Issuance Of Convertible Notes
DebtDiscountRecognizedFromIssuanceOfConvertibleNotes
134500 usd
boty Debt Discount Recognized From Issuance Of Convertible Notes
DebtDiscountRecognizedFromIssuanceOfConvertibleNotes
29111 usd
boty Common Stock Issued For Exercise Of Warrants
CommonStockIssuedForExerciseOfWarrants
45984 usd
boty Common Stock Issued For Exercise Of Warrants
CommonStockIssuedForExerciseOfWarrants
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lingerie Fighting Championships, Inc. (the “Company”) is a Nevada corporation incorporated on November 29, 2006 under the name Sparking Events, Inc. The Company’s corporate name was changed to Xodtec Group USA, Inc. in June 2009, Xodtec LED, Inc. in May 2010, Cala Energy Corp. in September 2013 and Lingerie Fighting Championships, Inc. on April 1, 2015.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company focuses on developing, producing, promoting, and distributing entertainment through live entertainment events, digital home videos, broadcast television networks, video on demand, and digital media channels in the United States. It offers wrestling and mixed martial arts fights featuring women under the LFC brand name.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates and judgments. The Company bases its estimates and judgments on historical experience and other factors that it believes to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.</p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10391745158 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
90000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
350000000 shares
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
70000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4504844036 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3896928536 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5594708812 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0002
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6735297364 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0002
boty Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
157915500 shares
boty Warrants To Purchase Shares
WarrantsToPurchaseShares
1345000000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
445000 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6735297364 shares
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1344114 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1093440 usd
CY2024Q3 boty Convertible Notes Payable Default Current
ConvertibleNotesPayableDefaultCurrent
705974 usd
CY2023Q4 boty Convertible Notes Payable Default Current
ConvertibleNotesPayableDefaultCurrent
619530 usd
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
213000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
530405 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1838806 usd
CY2024Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
2946476 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12835 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295 usd
CY2024Q3 us-gaap Revenues
Revenues
23533 usd
CY2023Q3 us-gaap Revenues
Revenues
32455 usd
us-gaap Revenues
Revenues
103041 usd
us-gaap Revenues
Revenues
88758 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6489210574 shares
CY2024Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2946476 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1838806 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5637133523 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.0001
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
184883994 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0005
CY2023 boty Share Based Compensation Arrangements By Share Based Payment Award Options Redeemed In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsRedeemedInPeriodWeightedAverageExercisePrice
0
CY2023 boty Share Based Compensation Arrangement By Share Based Payment Award Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised
-227308705 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1345000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0002
boty Share Based Compensation Arrangements By Share Based Payment Award Options Redeemed In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsRedeemedInPeriodWeightedAverageExercisePrice
0
boty Share Based Compensation Arrangement By Share Based Payment Award Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised
-204411448 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0002
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
204411448 shares
us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
0.0002
boty Expected Term
ExpectedTerm
P5Y
CY2024Q3 boty Closing Market Price
ClosingMarketPrice
0.0002
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5594708812 shares
CY2024Q3 us-gaap Notes Payable
NotesPayable
340000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
340000 usd
CY2021Q1 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
150000000 shares
CY2021Q1 boty Warrants Price Per Share
WarrantsPricePerShare
0.002
CY2021Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
35000 usd
CY2021Q1 boty Warrants Derivative Amount
WarrantsDerivativeAmount
265000 usd
CY2021Q1 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
300000 usd
CY2021Q4 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
50000000 shares
CY2021Q4 boty Warrants Price Per Share
WarrantsPricePerShare
0.0008
CY2021Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
9000 usd
CY2021Q4 boty Warrants Derivative Amount
WarrantsDerivativeAmount
31000 usd
CY2021Q4 boty Debt Instrument Aggregate Discount
DebtInstrumentAggregateDiscount
40000 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
148444 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
98108 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
64016 usd
CY2024Q3 boty Convertible Note Payable Gross Current
ConvertibleNotePayableGrossCurrent
114892 usd
CY2023Q4 boty Convertible Note Payable Gross Current
ConvertibleNotePayableGrossCurrent
84428 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
820866 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
703958 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
147483 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
126093 usd
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
677889 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2634867 usd
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
29111 usd
CY2023 boty Reduction Of Derivative Liabilities From Exercise Of Warrants
ReductionOfDerivativeLiabilitiesFromExerciseOfWarrants
-64683 usd
CY2023 boty Addition Of New Derivative Liabilities Upon Issuance Of Warrants As Debt Discount
AdditionOfNewDerivativeLiabilitiesUponIssuanceOfWarrantsAsDebtDiscount
59000 usd
CY2023 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
101123 usd
CY2023 boty Gain Loss On Change In Fair Value Of The Derivative Liability
GainLossOnChangeInFairValueOfTheDerivativeLiability
-920612 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
127500 usd
boty Reduction Of Derivative Liabilities From Exercise Of Warrants
ReductionOfDerivativeLiabilitiesFromExerciseOfWarrants
-45984 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
323528 usd
boty Gain Loss On Change In Fair Value Of The Derivative Liability
GainLossOnChangeInFairValueOfTheDerivativeLiability
702626 usd
CY2024Q3 boty Day One Loss Due To Derivative Liabilities On Convertible Notes And Warrants
DayOneLossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrants
120518 usd
CY2023Q3 boty Day One Loss Due To Derivative Liabilities On Convertible Notes And Warrants
DayOneLossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrants
0 usd
boty Day One Loss Due To Derivative Liabilities On Convertible Notes And Warrants
DayOneLossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrants
323528 usd
boty Day One Loss Due To Derivative Liabilities On Convertible Notes And Warrants
DayOneLossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrants
0 usd
CY2024Q3 boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
381710 usd
CY2023Q3 boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
423719 usd
boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
702626 usd
boty Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants
GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants
-606803 usd
CY2024Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
502228 usd
CY2023Q3 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
423719 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
1026154 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-606803 usd
CY2024Q3 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
721128 usd
CY2023Q4 boty Related Party Transaction Amounts Of Transaction Accounts Payable
RelatedPartyTransactionAmountsOfTransactionAccountsPayable
642128 usd

Files In Submission

Name View Source Status
0001640334-25-000046-index-headers.html Edgar Link pending
0001640334-25-000046-index.html Edgar Link pending
0001640334-25-000046.txt Edgar Link pending
0001640334-25-000046-xbrl.zip Edgar Link pending
boty-20240930.xsd Edgar Link pending
boty_10q.htm Edgar Link pending
boty_ex311.htm Edgar Link pending
boty_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
boty-20240930_cal.xml Edgar Link unprocessable
boty-20240930_def.xml Edgar Link unprocessable
boty-20240930_lab.xml Edgar Link unprocessable
boty-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
boty_10q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending